Welcome to the 4th Brain Barriers Summit
Highlighting pioneering research in barrier transport technology to bring drugs more effectively to target cells, the Brain Barriers Summit is uniquely placed to inform therapeutic development. Brainstorm strategic considerations, sampling methods, validation concerns and safety issues in this ever-expanding space with leaders in the field. Hear from industry experts developing robust tools in preclinical studies to enable validated proof-of-concept work and increased success in clinical trial.
The challenge of crossing the barriers of the CNS with successful clinical endpoints can be met, cement your place amongst the innovators on that journey.
Highlights for 2022:
Explore translation from model to NHP to man with Ossianix and JCR Pharmaceuticals. Applying insights and lessons learned to implement new strategic considerations in your pipeline.
Uncover the latest advancements in alternative delivery methods with Noveome and Cerebral Therapeutics to evaluate the most effective strategies by molecule.
Detail pharmacokinetic and dosing strategies with Sanofi and Vertex to inform better efficacy profiles.
Delve into the breadth of barrier penetration technology ranging from AAV vectors, exosomes to focussed ultrasound with ArunA Bio and Columbia University. Contemplate the approaches made to innovate transport across the BBB.
Access the ground-breaking studies on barrier biology with Cleveland Clinic and University of Minnesota to capitalise on novel receptors and pathophysiological knowledge to aid in drug discovery.